BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2484704)

  • 1. Effects of SIN-1 on isolated canine basilar arteries.
    Katusic ZS; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S72-5. PubMed ID: 2484704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins.
    Miller VM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S67-71. PubMed ID: 2484703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism underlying the inhibitory interaction between the nitrovasodilator SIN-1 and the endothelium.
    Flavahan NA; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S86-90. PubMed ID: 2484707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subarachnoid hemorrhage and the role of potassium channels in relaxations of canine basilar artery to nitrovasodilators.
    Onoue H; Katusic ZS
    J Cereb Blood Flow Metab; 1998 Feb; 18(2):186-95. PubMed ID: 9469162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog.
    Schini VB; Bond R; Gao Y; Illiano S; Junquero DC; Mombouli JV; Nagao T; Smart F; Vanhoutte PM
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S10-6. PubMed ID: 7504762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
    Govantes C; Rodríguez-Martínez MA; Marín J
    Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and effects of cationic polypeptides in canine cerebral arteries.
    Kinoshita H; Katusic ZS
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):470-80. PubMed ID: 9143230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels.
    Lüscher TF; Richard V; Yang ZH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S76-80. PubMed ID: 2484705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
    Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
    Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
    Kukovetz WR; Holzmann S
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S40-6. PubMed ID: 2484698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors.
    Onoue H; Katusic ZS
    Stroke; 1997 Jun; 28(6):1264-70; discussion 1270-1. PubMed ID: 9183360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery.
    Cosentino F; Sill JC; Katusić ZS
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H413-8. PubMed ID: 8383455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SIN-1 on electrical responses of the smooth muscle of the canine saphenous vein.
    Komori K; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S62-6. PubMed ID: 2484702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
    Pieper GM; Clarke GA; Gross GJ
    J Pharmacol Exp Ther; 1994 May; 269(2):451-6. PubMed ID: 8182511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
    Kanamaru K; Waga S; Kojima T; Fujimoto K
    No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HN-10200 causes endothelium-independent relaxations in isolated canine arteries.
    Cosentino F; Schirger A; Katusić ZS
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):159-65. PubMed ID: 1382554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local anesthetic drugs reduce endothelium-dependent relaxations of porcine ciliary arteries.
    Meyer P; Flammer J; Lüscher TF
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2730-6. PubMed ID: 8344795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H; Fret HR; Herman AG
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impairment of endothelium-dependent relaxations in reversed vein grafts is associated with a reduced production of cyclic guanosine monophosphate.
    Komori K; Schini VB; Gloviczki P; Bourchier RG; Vanhoutte PM
    J Vasc Surg; 1991 Jul; 14(1):67-75. PubMed ID: 1648144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.